Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study - Quiz - MDSpire

Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study

  • By

  • Junhyuk Seo

  • Taerim Kim

  • Ju-Hyun Kim

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study

  • by Junhyuk Seo, Taerim Kim, Ju-Hyun Kim

  • June 15, 2026

Related Content

Editorial: AntibodyPlus therapeutics in oncology: innovative mechanisms, therapeutic strategies, and clinical advances

Editorial: Innate lymphoid cells in cancer: volume II

Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis